2008-11-19 06:23:01 - InterMune Inc. - SWOT Analysis - a new market research report on http://www.companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/InterMune-In ..

Datamonitor´s InterMune, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

InterMune is a biopharmaceutical company focused on developing and commercializing therapies in pulmonology and hepatology. The company currently markets Actimmune which is indicated for reducing the frequency and severity of serious infections associated with chronic granulomatous disease (CGD) and for delaying time to disease progression in patients with severe, malignant osteopetrosis. InterMune primarily operates in the US. It is headquartered in Brisbane, California and employs about 130 people. The company recorded revenues of $66.7 million during the

 

 

financial year (FY) ended December 2007, a decrease of 26.5% over 2006. The decrease was primarily attributable to decline in Actimmune sales during the year. The operating loss of the company was $106.9 million during FY2007, as compared to an operating loss of $90.7 million in 2006. The net loss was $89.6 million in FY2007, as compared to a net loss of $107.2 million in 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available